Repositorio Dspace

Listar por autor "La-Casta, Adelaida"

Listar por autor "La-Casta, Adelaida"

Ordenar por:Orden:Resultados:

  • Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study 
    Vera, Ruth; Gómez, María-Luisa; Ayuso, Juan-Ramón; Figueras, Joan; García-Alfonso, Pilar; Martínez, Virginia; La-Casta, Adelaida; Ruiz-Casado, Ana; Safont, María-José; Aparicio, Jorge; Campos, Juan-Manuel; Camara, Juan-Carlos; Martín-Richard, Marta; Montagut, Clara; Pericay, Carles; Vieitez, José-María; Falco, Esther; Jorge, Mónica; Marín, Miguel; Salgado, Mercedes; Viudez, Antonio (MDPI, 2020-08)
    Background: The prospective phase IV AVAMET study was undertaken to correlate response evaluation criteria in solid tumors (RECIST)-defined response rates with computed tomography-based morphological criteria (CTMC) and ...
  • Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin 
    Capdevila, Jaume; Hernando, J; Teule, A; López, C; García-Carbonero, R; Benavent, M; Custodio, Ana-Belén; García-Álvarez, A; Cubillo, A; Alonso, V; Carmona-Bayonas, Alberto; Alonso-Gordoa, Teresa; Crespo, G; Jiménez-Fonseca, Paula; Blanco, M; Viudez, A; La-Casta, Adelaida; Sevilla, I; Segura, A; Llanos, M; Landolfi, S; Nuciforo, P; Manzano, José-Luis (NATURE PORTFOLIO, 2023-05)
    Single immune checkpoint blockade in advanced neuroendocrine neoplasms (NENs) shows limited efficacy; dual checkpoint blockade may improve treatment activity. Dune (NCT03095274) is a non-randomized controlled multicohort ...
  • Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry 
    López-López, Carlos; Martínez-de-Castro, Eva; Fernández-Montes, Ana; Jiménez-Orozco, Encarnación; López-Peraita, Sandra; Vera, Ruth; Cerdá, Paula; Calvo, Mariona; García-Paredes, Beatriz; de-Mena, Miriam-Lobo; La-Casta, Adelaida; Gallego, Javier; Adeva, Jorge; Cano-Cano, Juana-M; Ruiz-Casado, Ana; Vidal-Tocino, Rosario; García-García, Teresa; Pazo-Cid, Roberto; Rodríguez-Garrote, Mercedes; Sastre, Javier (SPRINGER INT PUBL AG, 2025-08-09)
    PURPOSE: Characterization of the management and outcomes of patients diagnosed with hepatocellular carcinoma (HCC) and treated with systemic therapy who were included in the Spanish gastrointestinal RETUD registry. ...
  • Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study 
    García-Alfonso, Pilar; Jiménez-Fonseca, Paula; Soto-Alsar, Javier; Baraibar, Iosune; Santos, Cristina; La-Casta, Adelaida; Ghanem, Ismael; Pulido-Cortijo, Gema; Marino-Méndez, Axel; Pazo-Cid, Roberto; Vera, Ruth; Melian, Marcos; Alcaide, Julia; Grana, Begoña; Páez, David; Gallego, Inmaculada; Lobo-de-Mena, Miriam; Borregon-Rivilla, Miguel; Fernández-Montes, Ana; Martínez-de-Castro, Eva; Carmona-Bayonas, Alberto; Aranda, Enrique (OXFORD UNIV PRESS, 2024-11-16)
    INTRODUCTION: The initial SARS-CoV-2 pandemic wave in Spain in 2020 precipitated significant paradigm shifts in gastrointestinal oncology patient management. This study captures the "Zeitgeist" of this period by analyzing ...
  • Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study 
    García-Alfonso, Pilar; Jiménez-Fonseca, Paula; Soto-Alsar, Javier; Baraibar, Iosune; Santos, Cristina; La-Casta, Adelaida; Ghanem, Ismael; Pulido-Cortijo, Gema; Marino-Mendez, Axel; Pazo-Cid, Roberto; Vera, Ruth; Melian, Marcos; Alcaide, Julia; Grana, Begoña; Paez, David; Gallego, Inmaculada; Lobo-de-Mena, Miriam; Borregón-Rivilla, Miguel; Fernández-Montes, Ana; Martínez-de-Castro, Eva; Carmona-Bayonas, Alberto; Aranda, Enrique (OXFORD UNIV PRESS, 2025-08-04)
    INTRODUCTION: The initial SARS-CoV-2 pandemic wave in Spain in 2020 precipitated significant paradigm shifts in gastrointestinal oncology patient management. This study captures the "Zeitgeist" of this period by analyzing ...